Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1999
10/21/1999WO1999052550A1 Polymer particle vaccine delivery system
10/21/1999WO1999052549A1 Adjuvant compositions
10/21/1999WO1999052547A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999WO1999052545A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/21/1999WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999WO1999052538A1 Composition containing a herbal medicinal substance and a pharmaceutical drug
10/21/1999WO1999052537A1 Anti-bacterial protein extracts from seeds of marigold and paprika
10/21/1999WO1999052515A2 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040061A3 Novel dihydroxyhexanoic acid derivatives
10/21/1999WO1999035156B1 Novel macrolides
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999DE19817264A1 New dihydropyrimidine derivatives and their corresponding mesomers useful as antiviral agents
10/21/1999DE19816780A1 New tryptamine derivatives useful as antibacterial agents for treating infections in humans and especially animals
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999CA2327807A1 Anti-bacterial protein extracts from seeds of marigold and paprika
10/21/1999CA2327431A1 Pharmaceutical composition
10/21/1999CA2325939A1 Vaccine
10/21/1999CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999CA2324988A1 Methods for treatment and prevention of infections
10/21/1999CA2324981A1 Peptides
10/21/1999CA2323733A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999CA2321181A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999CA2294018A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950059A1 Cyclic sulfone derivatives
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0949929A1 Use of plant extract for inhibition of haemophilus influenzae
10/20/1999EP0766689B1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof
10/20/1999EP0717738B1 Substituted oxazine and thiazine oxazolidinone antimicrobials
10/20/1999CN1232466A Phosphonate nucleotide compounds
10/20/1999CN1232461A Neuraminic acid compounds
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232447A Hydroxamic acid derivs.
10/20/1999CN1232401A Anti-chlamydial methods and materials
10/20/1999CN1232399A Inhibitors of cysteine protease
10/20/1999CN1232395A Pharmaceutical compound comprising polyamines substd. with electron-affinic groups
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999CN1232037A Process for preparation of azithromycin dihydrate
10/20/1999CN1231892A Compound antibacterial anti-inflammatory for animals and poultry
10/20/1999CN1045774C Substd. arylthioalkylthiopyridines, their preparing method and pharmaceutical use
10/19/1999US5969184 Amide compounds
10/19/1999US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999US5969141 Intermediates for 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarbox ylic acid antibacterial agents
10/19/1999US5969139 Inhibitors of herpes simplex virus thymidine kinase
10/19/1999US5969132 Macrocyclic difluorostatone derivatives useful as antiviral agents
10/19/1999US5969130 Meningococcal polysaccharide conjugate vaccines
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5969093 Secreted proteins
10/19/1999US5968970 Treatment of hiv
10/19/1999US5968962 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
10/19/1999US5968961 Pharmaceutical compositions of tizoxanide and nitazoxanide
10/19/1999US5968945 Immunotherapeutic agents
10/19/1999US5968939 Antibiotics from aminooxobenzopyran compounds
10/19/1999US5968910 Two or three compounds which do not select for same mutantstrains; preventtion or treatment of htlv infections
10/19/1999US5968909 Method of modulating gene expression with reduced immunostimulatory response
10/19/1999US5968907 1-thiogalactose derivatives
10/19/1999US5968903 Helicobacter and antigrowth agents, using somatostatin or agonist
10/19/1999US5968780 Dendritic cell-derived growth factor
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999US5968733 Mycobacteriophages and uses thereof
10/19/1999US5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor
10/19/1999US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999US5968521 Conjugate vaccine for group B Streptococcus
10/19/1999US5968514 Polypeptides and proteins for immunology
10/17/1999CA2269262A1 Substituted tricyclics
10/14/1999WO1999051751A1 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection
10/14/1999WO1999051750A1 Medicaments for inducing cytotoxic t-cells
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051618A1 Novel crystalline forms of an antiviral benzimidazole compound
10/14/1999WO1999051617A2 FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
10/14/1999WO1999051616A1 15-membered lactams ketolides with antibacterial activity
10/14/1999WO1999051613A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051604A2 Process for the production of purine derivatives
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051273A1 Gelling ophthalmic compositions containing xanthan gum
10/14/1999WO1999051269A1 Adjuvant-containing vaccines
10/14/1999WO1999051267A1 Hiv-specific cytotoxic t-cell responses
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051265A1 Nucleic acid encoding hyaluronan synthase and methods of use
10/14/1999WO1999051251A1 Use of extracts of bearberry leaves (arctostaphylos uva ursi), birch leaves (betula), horsetail (equisetum) and stinging nettle (urtica)
10/14/1999WO1999051250A1 Use of extracts of echinacea pallida and echinacea angustifolia, dandelion (taraxacum) and plantain (plantago)
10/14/1999WO1999051249A1 Herbal composition for the prophylaxis and treatment of aids
10/14/1999WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases
10/14/1999WO1999051239A1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
1 ... 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 ... 1798